Arbutus Biopharma Corporation (ABUS) has seen some recent action in the market and its common shares finished trading at $1.9100 yesterday. Investors are starting to take notice of ABUS as the common shares traded as high as $2.0650 and as low as $1.9000 in the last market session.

Arbutus Biopharma Corporation (ABUS) average trading volume is 1.26M. However, in the last market session Arbutus Biopharma Corporation (ABUS) exchanged 2,579,397 shares. The 1st downside support level on ABUS is $1.88 and the 1st upside resistance level on ABUS is $3.47. ABUS 50-day moving average is $1.8979 and ABUS two hundred day moving average is $2.2149.

Arbutus Biopharma Corporation (ABUS) current performance has been specified by the recent movement in ABUS common shares. ABUS has performed -19.07% over the past 4 weeks, ABUS has performed 32.64% over the past quarter and ABUS has shown -19.07% over the past 12 months. Arbutus Biopharma Corporation (ABUS) has a 12 month range of $0.8200 to $3.6600. Arbutus Biopharma Corporation (ABUS) is trading 132.53% from its 12 month low and -47.81% from its 12 month high. Arbutus Biopharma Corporation (ABUS) is indicating a 1.27% short float indicating the sum short in the float.

ABUS has 67.68M shares outstanding and 44.46M shares in the float. Arbutus Biopharma Corporation (ABUS) currently has a market cap of $135.21M and income of -155.70M. The EPS next quarter for ABUS is -0.23 and projected EPS next year is 4.50%. The market cap of Arbutus Biopharma Corporation (ABUS) at $135.21M represents how many Investors own shares of ABUS and is based off the last price ($1.9100) of ABUS and the sum of shares outstanding (67.68M) with Arbutus Biopharma Corporation (ABUS).

Arbutus Biopharma Corporation (ABUS) has aggregate cash (mrq) of 84.89M, aggregate cash per share (mrq) of 1.23, aggregate debt of ABUS is at 3.29M and aggregate debt/equity (mrq) is 4.50. . Arbutus Biopharma Corporation (ABUS) running cash flow (ttm) is -69.88M, ABUS leveraged free cash flow (ttm) is -40.09M.

ABUS is trading -6.04% below (bearish) its SMA20, 16.19% above (bullish) its SMA50 and -1.79% below (bearish) its SMA200.